Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 2361 - 2368 of 12107 results

USCIS Expands Eligibility for Premium Processing Upgrades of EB-1C Multinational Executive/Manager and EB-2 National Interest Waiver Petitions

July 25, 2022| Alert| Viewpoint

ML Strategies Outlook: Federal Action Post-Dobbs Decision

July 25, 2022| Blog| Viewpoint

SEC Tests Its Reach With Coinbase Insider Trading Case

July 25, 2022| News

Judge Albright Holds Willful Infringement Pleading Does Not Require Allegations of Egregious Infringing Behavior

July 22, 2022| Blog| Viewpoint

Litigator of the Week Runners-Up and Shout Outs

July 22, 2022| News

Regulator Turf Battles & Twitter Sleuths - Takeaways from the insider trader tipping scheme against a former Coinbase Employee

July 22, 2022| Blog| Viewpoint

Protecting Health Information Post Roe – Part 2: Steps for Health Care Providers

July 21, 2022| Blog| Viewpoint

Political Tensions up The Ante For SEC Green Agenda

July 21, 2022| News

News & Press Releases

SEC’s Pharmaceutical Insider Trading Case Yields Quick Deals

August 19, 2025

Bloomberg Law featured a statement from Member Jason P.W. Halperin in its coverage of a pharmaceutical insider trading case brought by the SEC. Jason and the Mintz team of Sean Prosser and Elizabeth Platonova represented Robert Yedid in reaching a resolution in which the client pled guilty and, along with the other defendants, entered into consent orders with the SEC.

Mintz Advises Oppenheimer & Co. and Initial Purchasers in $475M Convertible Senior Notes Offering by WisdomTree

August 19, 2025

Mintz represented Oppenheimer & Co., as sole book-running manager, and Craig-Hallum Capital Group and Northland Securities, as co-managers, in the private placement of $475 million aggregate principal amount of 4.625% Convertible Senior Notes due 2030 issued by WisdomTree, Inc (NYSE: WT) (“WisdomTree”). The notes were sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933.

Mintz Advises Underwriters in Assembly Biosciences' $175 Million Underwritten Offering and Concurrent Private Placement

August 18, 2025

Mintz advised the underwriters in connection with Assembly Biosciences, Inc.’s underwritten offering of an aggregate of 5,591,840 shares of common stock and pre-funded warrants to purchase up to 1,040,820 shares of common stock, together with accompanying Class A and Class B warrants to purchase up to an aggregate of 6,632,660 shares of common stock at a combined price per share of common stock and accompanying Class A warrant and Class B warrant of $19.60 and a combined price per pre-funded warrant and accompanying Class A warrant and Class B warrant of $19.599.

View all News and Press Releases